Efgartigimod Alfa
ATC L04AL01 · 7 markets · 16 records
Efgartigimod Alfa
Forms
AU 4 records · 4 strengths
- 20 mg/mLinjectionVYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial
- 200 mg/mLinjectionVYVGART efgartigimod alfa 1000 mg/5 mL solution for injection prefilled syringe
- 180 mg/mLinjectionVYVGART efgartigimod alfa 1000 mg/5.6 mL solution for injection vial
Records without a stated strength · 1 VYVGART
US 3 records · 3 strengths
- 200 mginjectionVYVGART Hytrulo
- 180 mginjectionVYVGART Hytrulo
- 20 mginjectionVYVGART
GB 2 records · 2 strengths
- 1,000 mg/5.6 mLinjectionVyvgart 1000mg/5.6ml solution for injection vials
- 400 mg/20 mLinjectionVyvgart 400mg/20ml concentrate for solution for infusion vials
CA 2 records · 2 strengths
- 200 mgliquidVYVGART SC
- 20 mgliquidVYVGART
ES 2 records · 2 strengths
- 1,000 mginjectionVYVGART PRECARGADA
- 20 mg/1 mLinjectionVYVGART
SG 1 records · 1 strengths
- 20 mg/mLinjectionVYVGART CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 VYVGART
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.